A carregar...
Aquaporin-4 antibodies in patients treated with natalizumab for suspected MS
OBJECTIVE: To evaluate (1) the frequency of aquaporin-4 antibody (AQP4-ab)-seropositive cases among patients treated with natalizumab (NAT) and previously diagnosed with MS (MS(NAT)) in a nationwide cohort, (2) the clinical course of NAT-treated AQP4-ab–seropositive neuromyelitis optica spectrum dis...
Na minha lista:
| Publicado no: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5473957/ https://ncbi.nlm.nih.gov/pubmed/28642888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000363 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|